USANA Health Sciences (USNA) Tops Q3 EPS by 27c; Trims Outlook
Get Alerts USNA Hot Sheet
Price: $43.42 +0.95%
EPS Growth %: -33.7%
Financial Fact:
Total operating expenses: 173.41M
Today's EPS Names:
ESCA, LICT, NKSH, More
EPS Growth %: -33.7%
Financial Fact:
Total operating expenses: 173.41M
Today's EPS Names:
ESCA, LICT, NKSH, More
Join SI Premium – FREE
USANA Health Sciences (NYSE: USNA) reported Q3 EPS of $2.40, $0.27 better than the analyst estimate of $2.13. Revenue for the quarter came in at $254.2 million versus the consensus estimate of $263.37 million.
GUIDANCE:
USANA Health Sciences sees FY2016 EPS of $7.90-$8.10, versus prior guidance of $7.90-$8.20 and the consensus of $8.10. USANA Health Sciences sees FY2016 revenue of $1.00-1.01 billion, versus the consensus of $1.03 billion.
For earnings history and earnings-related data on USANA Health Sciences (USNA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Elevance Health (ELV) hikes 2024 earnings outlook, shares climb
- Apogee Enterprises (APOG) Tops Q4 EPS by 13c ; Offers Guidance
- Iridium Communications (IRDM) Reports In-Line Q1 EPS; offers outlook
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!